Total Funding
94
89
Total FundingGrant raised
Growth Score
3 pts
Heat Score
10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
21620
ImmunoForge is a developer of a new drug intended for treating sarcopenia and cancer.
- Kiho Chang: CEO
Lee Eun-gyu: Chief Quality Officer
About the Company
ImmunoForge is a developer of a new drug intended for treating sarcopenia and cancer. The company has a solution for sarcopenia based on its drug repurposing patents as well as a strong kinase inhibitor pipeline for genomically defined rare cancers, such as chronic myelogenous leukemia, enabling patients to get cured quickly.
